Biology of GFAP-expressing neural progenitors
Biology of GFAP-expressing neural progenitors
批准号:
6989043
负责人:
Michael V Sofroniew
金额:
$31.4万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2008-12-31
中文摘要
描述(由申请人提供):大量证据表明,新神经元的诞生(神经发生)在成人大脑的特定区域持续一生,包括人类。产生新神经元的成年神经祖细胞的生物学是相当有趣的,不仅反映了它们潜在的功能作用,而且还反映了它们在治疗或修复神经疾病或损伤方面的潜力。成人神经祖细胞的身份和起源是有争议的。实验表明,部分成体神经祖细胞表达胶质原纤维酸性蛋白(GFAP),具有星形胶质细胞的某些特征。这些观察结果提出了问题和挑战。考虑到表达GFAP的星形胶质细胞在神经损伤、疾病和修复中的基本作用,了解星形胶质细胞和成人神经祖细胞之间的关系(如果有的话)是很重要的。我们对表达gmap的星形胶质细胞有长期的兴趣,并开发了转基因小鼠模型来研究这些细胞在神经损伤和修复中的作用。在这里,我们应用这些模型来确定(i)体内和体外表达gmap -的细胞对成人神经发生的相对贡献(如果有的话),(ii)是否所有表达gmap -的胶质细胞都具有神经发生潜力,或者这种潜力是否与表现出不同表型特征的细胞亚群相关,以及(iii)调节表达gmap -的神经祖细胞神经发生潜力的因素,特别是在脑损伤后。为此,我们使用了体外和体内技术以及几种转基因小鼠模型,这些模型允许(a)消融表达gmap的细胞,(b)对表达gmap的细胞的后代进行谱系分析和命运定位,以及(c)从表达gmap的细胞中特异性地删除基因。我们的前期工作和初步数据与以下几个假设一致:(1)成人前脑中主要的神经祖细胞表达GFAP;(2)并非所有表达gap的胶质细胞都具有神经发生潜能,神经发生潜能与表达gap的细胞的存在相关,这些细胞表现出与放射状胶质细胞相似的某些表型特征;(3)表达gfap的祖细胞的多能性可受环境条件的影响。本文提出的研究结果将为确定成体神经祖细胞的身份和调控,以及确定神经祖细胞与对损伤和疾病作出反应的星形胶质细胞之间的关系提供基础信息。了解表达gfap的神经祖细胞的生物学及其与星形胶质细胞的关系,可能会为改善损伤或疾病后的神经修复提供新的研究途径。
英文摘要
DESCRIPTION (provided by applicant): Substantial evidence indicates that the birth of new neurons (neurogenesis) continues throughout life in specific regions of the adult brain, including humans. The biology of the adult neural progenitors that give rise to new neurons is of considerable interest reflecting not only their potential functional roles, but also their potential for treatment or repair of neurological illness or injury. The identity and origin of adult neural progenitors are controversial. Experimental evidence suggests that some adult neural progenitors express glial fibrillary acidic protein (GFAP) and exhibit certain characteristics of astroglia. These observations raise questions and challenges. Given the fundamental roles of GFAP expressing astroglia in neural injury, disease and repair, it is important to understand the relationships, if any, between astroglia and adult neural progenitors. We have a longstanding interest in GFAP-expressing astroglia, and have developed transgenic mouse models to study these cells in neural injury and repair. Here, we apply these models to determine (i) the relative contribution, if any, of GFAP-expressing cells to adult neurogenesis in vivo and in vitro, (ii) whether all GFAP-expressing glia have neurogenic potential or whether this potential is associated with a subpopulation of cells that exhibits distinct phenotypic characteristics, and (iii) factors that regulate the neurogenic potential of GFAP-expressing neural progenitors, in particular after brain injury. To do so we use in vitro and in vivo techniques and several transgenic mouse models that allow (a) ablation of GFAP-expressing cells, (b) lineage analysis and fate mapping of progeny of GFAP-expressing cells, and (c) deletion of genes specifically from GFAP-expressing cells. Our preparatory work and preliminary data are consistent with several hypotheses including: (1) the predominant neural progenitors in adult forebrain express GFAP; (2) not all GFAP-expressing glia have neurogenic potential, neurogenic potential correlates with the presence of GFAP-expressing cells that exhibit certain phenotypic characteristics similar to radial glia; (3) the multipotent potential of GFAP-expressing progenitors can be manipulated by environmental conditions. Findings from studies proposed here will contribute fundamental information towards establishing the identity and regulation of adult neural progenitor cells, and towards defining the relationships between neural progenitors and the astroglia that respond to injury and disease. Understanding the biology of GFAP-expressing neural progenitors and their relationship to astroglia, which are widespread throughout the central nervous system, may reveal novel research avenues towards improving neural repair after injury or disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering astroglial bridges for axons across severe SCI lesions
-
批准号:10397401
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Injectable biomaterial depots to manipulate scar and foster axon growth after SCI
-
批准号:9054178
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Engineering astroglial bridges for axons across severe SCI lesions
-
批准号:10599271
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Injectable biomaterial depots to manipulate scar and foster axon growth after SCI
-
批准号:9265336
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Injectable biomaterial depots to manipulate scar and foster axon growth after SCI
-
批准号:8697663
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Engineering astroglial bridges for axons across severe SCI lesions
-
批准号:9893911
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:7869128
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:7555628
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:7461260
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:7998188
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:8197050
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrogliosis: STAT3
-
批准号:7740154
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2008
-
负责人:Michael V Sofroniew
-
依托单位:
Biology of GFAP-expressing neural progenitors
-
批准号:6707110
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2004
-
负责人:Michael V Sofroniew
-
依托单位:
Biology of GFAP-expressing neural progenitors
-
批准号:6826259
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2004
-
负责人:Michael V Sofroniew
-
依托单位:
Biology of GFAP-expressing neural progenitors
-
批准号:7159344
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2004
-
负责人:Michael V Sofroniew
-
依托单位:
Biology of GFAP-expressing neural progenitors
-
批准号:7359640
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2004
-
负责人:Michael V Sofroniew
-
依托单位:
DESCENDING SPINAL PATHWAYS AND NEUROMUSCULAR PLASTICITY
-
批准号:6786430
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2003
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrocyte Biology
-
批准号:6541902
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2002
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrocyte Biology
-
批准号:6645682
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2002
-
负责人:Michael V Sofroniew
-
依托单位:
Molecular Dissection of Reactive Astrocyte Biology
-
批准号:6689963
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2002
-
负责人:Michael V Sofroniew
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
-
批准号:82371465
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李龙宣
-
依托单位:
小胶质细胞调控Müller glia基础上感光细胞再生的机制研究
-
批准号:81301080
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:李玉皓
-
依托单位:
神经胶质成熟因子-β对肝星状细胞活化和肝纤维化的影响及其机制研究
-
批准号:30800508
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:饶慧瑛
-
依托单位:
白质消融性白质脑病中胶质细胞选择性受累的机制研究
-
批准号:30872793
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:吴晔
-
依托单位:
白质消融性白质脑病致病基因EIF2B5的突变功能研究
-
批准号:30772355
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2007
-
负责人:姜玉武
-
依托单位: